Long term metabolic and renal outcomes of kidney donors compared to controls with excellent kidney function

Abstract Background Only few studies of living kidney donors have included controls that were similarly healthy, including excellent kidney function. Methods In this study, we aimed to estimate long term metabolic and renal outcome in a cohort of 211 living donors compared to two control groups: pai...

Full description

Bibliographic Details
Main Authors: Ayelet Grupper, Yoel Angel, Aharon Baruch, Idit F. Schwartz, Doron Schwartz, Richard Nakache, Yaacov Goykhman, Paulina Katz, Ido Nachmany, Nir Lubezky, Talia Weinstein, Moshe Shashar, Orit Kliuk Ben-Bassat, Shlomo Berliner, Ori Rogowski, David Zeltser, Itzhak Shapira, Shani Shenhar-Tsarfaty
Format: Article
Language:English
Published: BMC 2019-01-01
Series:BMC Nephrology
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12882-019-1214-4
_version_ 1828521973699837952
author Ayelet Grupper
Yoel Angel
Aharon Baruch
Idit F. Schwartz
Doron Schwartz
Richard Nakache
Yaacov Goykhman
Paulina Katz
Ido Nachmany
Nir Lubezky
Talia Weinstein
Moshe Shashar
Orit Kliuk Ben-Bassat
Shlomo Berliner
Ori Rogowski
David Zeltser
Itzhak Shapira
Shani Shenhar-Tsarfaty
author_facet Ayelet Grupper
Yoel Angel
Aharon Baruch
Idit F. Schwartz
Doron Schwartz
Richard Nakache
Yaacov Goykhman
Paulina Katz
Ido Nachmany
Nir Lubezky
Talia Weinstein
Moshe Shashar
Orit Kliuk Ben-Bassat
Shlomo Berliner
Ori Rogowski
David Zeltser
Itzhak Shapira
Shani Shenhar-Tsarfaty
author_sort Ayelet Grupper
collection DOAJ
description Abstract Background Only few studies of living kidney donors have included controls that were similarly healthy, including excellent kidney function. Methods In this study, we aimed to estimate long term metabolic and renal outcome in a cohort of 211 living donors compared to two control groups: paired-matched controls, and another control group of 2534 healthy individuals with excellent kidney function. Results Donors presented with higher estimated Glomerular Filtration Rate (eGFR): (97.6 ± 15.2 vs 96.1 ± 12.2 vs 94.5 ± 12.4 ml/min/1.73m2) and lower urine albumin to creatinine ratio (UACR) (4.3 ± 5.9 vs 5.9 ± 6.1 vs 6.1 ± 6.9 mg/g) for donors, matched controls and healthy controls, respectively (p <  0.001). In a mean follow up period of 5.5 for donors, donors presented with positive eGFR slopes during the first 3 years post donation, followed by negative slopes, compared to constantly negative slopes presented in the control group (p <  0.05). The variables related to the slope were being a donor, baseline eGFR, Body Mass Index (BMI) and age but not eGFR on the last day of follow-up or increased delta UACR. There was a significant increase in UACR in donors, as well as a higher rate of albuminuria, associated with a longer time since donation, higher pre-donation UACR and higher pre-donation BMI. Healthy controls had a lower BMI at baseline and gained less weight during the follow up period. Donors and controls had similar incidence of new onset diabetes mellitus and hypertension, as well as similar delta systolic and diastolic blood pressure. Donors were more likely to develop new onset metabolic syndrome, even after adjustment for age, gender and BMI. The higher incidence of metabolic syndrome resulted mainly from increased triglycerides and impaired fasting glucose criteria. However, prevalence of major cardiovascular events was not higher in this group. Conclusions Donors are at increased risk to develop features of the metabolic syndrome in addition to the expected mild reduction of GFR and increased urine albumin excretion. Future studies are needed to explore whether addressing those issues will impact post donation morbidity and mortality.
first_indexed 2024-12-11T19:59:08Z
format Article
id doaj.art-ad47f9d9704c491ba3dd478720d12f48
institution Directory Open Access Journal
issn 1471-2369
language English
last_indexed 2024-12-11T19:59:08Z
publishDate 2019-01-01
publisher BMC
record_format Article
series BMC Nephrology
spelling doaj.art-ad47f9d9704c491ba3dd478720d12f482022-12-22T00:52:34ZengBMCBMC Nephrology1471-23692019-01-0120111110.1186/s12882-019-1214-4Long term metabolic and renal outcomes of kidney donors compared to controls with excellent kidney functionAyelet Grupper0Yoel Angel1Aharon Baruch2Idit F. Schwartz3Doron Schwartz4Richard Nakache5Yaacov Goykhman6Paulina Katz7Ido Nachmany8Nir Lubezky9Talia Weinstein10Moshe Shashar11Orit Kliuk Ben-Bassat12Shlomo Berliner13Ori Rogowski14David Zeltser15Itzhak Shapira16Shani Shenhar-Tsarfaty17Organ Transplantation Unit, Tel Aviv Sourasky Medical Center and Sackler Faculty of Medicine, Tel Aviv UniversityDepartment of Internal Medicine “C”, “D” and “E”, Tel Aviv Sourasky Medical Center and Sackler Faculty of Medicine, Tel Aviv UniversityOrgan Transplantation Unit, Tel Aviv Sourasky Medical Center and Sackler Faculty of Medicine, Tel Aviv UniversityNephrology Department, Tel-Aviv Sourasky Medical Center and Sackler Faculty of Medicine, Tel-Aviv UniversityNephrology Department, Tel-Aviv Sourasky Medical Center and Sackler Faculty of Medicine, Tel-Aviv UniversityOrgan Transplantation Unit, Tel Aviv Sourasky Medical Center and Sackler Faculty of Medicine, Tel Aviv UniversityOrgan Transplantation Unit, Tel Aviv Sourasky Medical Center and Sackler Faculty of Medicine, Tel Aviv UniversityOrgan Transplantation Unit, Tel Aviv Sourasky Medical Center and Sackler Faculty of Medicine, Tel Aviv UniversityOrgan Transplantation Unit, Tel Aviv Sourasky Medical Center and Sackler Faculty of Medicine, Tel Aviv UniversityOrgan Transplantation Unit, Tel Aviv Sourasky Medical Center and Sackler Faculty of Medicine, Tel Aviv UniversityNephrology Department, Tel-Aviv Sourasky Medical Center and Sackler Faculty of Medicine, Tel-Aviv UniversityNephrology Department, Tel-Aviv Sourasky Medical Center and Sackler Faculty of Medicine, Tel-Aviv UniversityNephrology Department, Tel-Aviv Sourasky Medical Center and Sackler Faculty of Medicine, Tel-Aviv UniversityDepartment of Internal Medicine “C”, “D” and “E”, Tel Aviv Sourasky Medical Center and Sackler Faculty of Medicine, Tel Aviv UniversityDepartment of Internal Medicine “C”, “D” and “E”, Tel Aviv Sourasky Medical Center and Sackler Faculty of Medicine, Tel Aviv UniversityDepartment of Internal Medicine “C”, “D” and “E”, Tel Aviv Sourasky Medical Center and Sackler Faculty of Medicine, Tel Aviv UniversityDepartment of Internal Medicine “C”, “D” and “E”, Tel Aviv Sourasky Medical Center and Sackler Faculty of Medicine, Tel Aviv UniversityDepartment of Internal Medicine “C”, “D” and “E”, Tel Aviv Sourasky Medical Center and Sackler Faculty of Medicine, Tel Aviv UniversityAbstract Background Only few studies of living kidney donors have included controls that were similarly healthy, including excellent kidney function. Methods In this study, we aimed to estimate long term metabolic and renal outcome in a cohort of 211 living donors compared to two control groups: paired-matched controls, and another control group of 2534 healthy individuals with excellent kidney function. Results Donors presented with higher estimated Glomerular Filtration Rate (eGFR): (97.6 ± 15.2 vs 96.1 ± 12.2 vs 94.5 ± 12.4 ml/min/1.73m2) and lower urine albumin to creatinine ratio (UACR) (4.3 ± 5.9 vs 5.9 ± 6.1 vs 6.1 ± 6.9 mg/g) for donors, matched controls and healthy controls, respectively (p <  0.001). In a mean follow up period of 5.5 for donors, donors presented with positive eGFR slopes during the first 3 years post donation, followed by negative slopes, compared to constantly negative slopes presented in the control group (p <  0.05). The variables related to the slope were being a donor, baseline eGFR, Body Mass Index (BMI) and age but not eGFR on the last day of follow-up or increased delta UACR. There was a significant increase in UACR in donors, as well as a higher rate of albuminuria, associated with a longer time since donation, higher pre-donation UACR and higher pre-donation BMI. Healthy controls had a lower BMI at baseline and gained less weight during the follow up period. Donors and controls had similar incidence of new onset diabetes mellitus and hypertension, as well as similar delta systolic and diastolic blood pressure. Donors were more likely to develop new onset metabolic syndrome, even after adjustment for age, gender and BMI. The higher incidence of metabolic syndrome resulted mainly from increased triglycerides and impaired fasting glucose criteria. However, prevalence of major cardiovascular events was not higher in this group. Conclusions Donors are at increased risk to develop features of the metabolic syndrome in addition to the expected mild reduction of GFR and increased urine albumin excretion. Future studies are needed to explore whether addressing those issues will impact post donation morbidity and mortality.http://link.springer.com/article/10.1186/s12882-019-1214-4Living kidney donorHypertensionAlbuminuriaeGFRMetabolic syndrome
spellingShingle Ayelet Grupper
Yoel Angel
Aharon Baruch
Idit F. Schwartz
Doron Schwartz
Richard Nakache
Yaacov Goykhman
Paulina Katz
Ido Nachmany
Nir Lubezky
Talia Weinstein
Moshe Shashar
Orit Kliuk Ben-Bassat
Shlomo Berliner
Ori Rogowski
David Zeltser
Itzhak Shapira
Shani Shenhar-Tsarfaty
Long term metabolic and renal outcomes of kidney donors compared to controls with excellent kidney function
BMC Nephrology
Living kidney donor
Hypertension
Albuminuria
eGFR
Metabolic syndrome
title Long term metabolic and renal outcomes of kidney donors compared to controls with excellent kidney function
title_full Long term metabolic and renal outcomes of kidney donors compared to controls with excellent kidney function
title_fullStr Long term metabolic and renal outcomes of kidney donors compared to controls with excellent kidney function
title_full_unstemmed Long term metabolic and renal outcomes of kidney donors compared to controls with excellent kidney function
title_short Long term metabolic and renal outcomes of kidney donors compared to controls with excellent kidney function
title_sort long term metabolic and renal outcomes of kidney donors compared to controls with excellent kidney function
topic Living kidney donor
Hypertension
Albuminuria
eGFR
Metabolic syndrome
url http://link.springer.com/article/10.1186/s12882-019-1214-4
work_keys_str_mv AT ayeletgrupper longtermmetabolicandrenaloutcomesofkidneydonorscomparedtocontrolswithexcellentkidneyfunction
AT yoelangel longtermmetabolicandrenaloutcomesofkidneydonorscomparedtocontrolswithexcellentkidneyfunction
AT aharonbaruch longtermmetabolicandrenaloutcomesofkidneydonorscomparedtocontrolswithexcellentkidneyfunction
AT iditfschwartz longtermmetabolicandrenaloutcomesofkidneydonorscomparedtocontrolswithexcellentkidneyfunction
AT doronschwartz longtermmetabolicandrenaloutcomesofkidneydonorscomparedtocontrolswithexcellentkidneyfunction
AT richardnakache longtermmetabolicandrenaloutcomesofkidneydonorscomparedtocontrolswithexcellentkidneyfunction
AT yaacovgoykhman longtermmetabolicandrenaloutcomesofkidneydonorscomparedtocontrolswithexcellentkidneyfunction
AT paulinakatz longtermmetabolicandrenaloutcomesofkidneydonorscomparedtocontrolswithexcellentkidneyfunction
AT idonachmany longtermmetabolicandrenaloutcomesofkidneydonorscomparedtocontrolswithexcellentkidneyfunction
AT nirlubezky longtermmetabolicandrenaloutcomesofkidneydonorscomparedtocontrolswithexcellentkidneyfunction
AT taliaweinstein longtermmetabolicandrenaloutcomesofkidneydonorscomparedtocontrolswithexcellentkidneyfunction
AT mosheshashar longtermmetabolicandrenaloutcomesofkidneydonorscomparedtocontrolswithexcellentkidneyfunction
AT oritkliukbenbassat longtermmetabolicandrenaloutcomesofkidneydonorscomparedtocontrolswithexcellentkidneyfunction
AT shlomoberliner longtermmetabolicandrenaloutcomesofkidneydonorscomparedtocontrolswithexcellentkidneyfunction
AT orirogowski longtermmetabolicandrenaloutcomesofkidneydonorscomparedtocontrolswithexcellentkidneyfunction
AT davidzeltser longtermmetabolicandrenaloutcomesofkidneydonorscomparedtocontrolswithexcellentkidneyfunction
AT itzhakshapira longtermmetabolicandrenaloutcomesofkidneydonorscomparedtocontrolswithexcellentkidneyfunction
AT shanishenhartsarfaty longtermmetabolicandrenaloutcomesofkidneydonorscomparedtocontrolswithexcellentkidneyfunction